Video centre

Learn more about the design of SHINGRIX

 

Discover the components and the mechanism of action of SHINGRIX.

View reconstitution instructions for SHINGRIX

You and your office staff can learn how to administer SHINGRIX step by step.

NACI recommendation for herpes zoster vaccination

Review the recommendation from the National Advisory Committee on Immunization (NACI) on SHINGRIX.

Who’s at risk of developing shingles?

 

Are your patients over 50 aware of their risk of developing shingles?

The burden of shingles

Shingles can result in a painful and blistering rash that can last several weeks.
SHINGRIX is not indicated for the treatment of HZ or PHN.

SHINGRIX: A 2-dose vaccine developed to prevent shingles

Discover the importance of the second dose of SHINGRIX.

Trademarks are owned by or licensed to the GSK group of companies.

©2021 GSK Group of Companies or its licensor.

PM-CA-SGX-WCNT-210001 | November 2021